ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,863, issued on Jan. 20, was assigned to CHUGAI SEIYAKU K.K. (Tokyo).
"Claudin-6 binding molecules and uses thereof" was invented by Naoki Kimura (Kanagawa, Japan), Tatsushi Kodama (Tokyo), Shinya Ishii (Kanagawa, Japan), Masaru Muraoka (Shizuoka, Japan) and Takayuki Kamikawa (Kanagawa, Japan).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antigen binding molecules that show binding activity towards Claudin-6 (CLDN6), methods for producing the antigen binding molecules, use of the antigen-binding molecules and immunoconjugates comprising the same in treating and/or preventing cancers, use of the antigen binding molecule...